Safety of ustekinumab for the treatment of psoriasis vulgaris with myotonic dystrophy

Eur J Dermatol. 2016 Apr 1;26(2):187-8. doi: 10.1684/ejd.2015.2688.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Dermatologic Agents / adverse effects
  • Dermatologic Agents / therapeutic use*
  • Female
  • Humans
  • Myotonic Dystrophy / complications*
  • Psoriasis / complications*
  • Psoriasis / drug therapy*
  • Ustekinumab / adverse effects
  • Ustekinumab / therapeutic use*

Substances

  • Dermatologic Agents
  • Ustekinumab